The role of GPCRs and homing molecules in the control and regionalization of mucosal immunity.
This project aims to investigate the role of GPCRs, particularly GPR35, in immune regionalization of mucosal tissues to enhance understanding and treatment of gut and airway diseases.
Projectdetails
Introduction
Mucosal immunity is essential to preserve homeostasis and for pathogen control within the gut and the airways. The emerging dogma of immune regionalization has opened new questions about which elements drive cell adaptation to different niches, and how this can be targeted to cure diseases.
Functional Diversity of Mucosal Tissues
The intestine and the airways are functionally diverse along their length, and disorders can differentially impact different mucosal tissue regions. Mucosa-associated lymphoid tissues (MALTs) are located along the intestine and the airways to drain selective tissue segments and support protective immunity.
Immune Regionalization and MALTs
Whether MALTs located in different tissue areas show immune regionalization remains poorly understood. Also, little is known about which molecules control such immune diversity.
Role of GPCRs
G protein-coupled receptors (GPCRs) are surface proteins important for cell migration and compartmentalization in lymphoid tissues, but their role in immune regionalization is not clear.
Proposed Methodology
We propose to apply a combination of imaging, flow cytometry, spatial gene editing, and sequencing techniques to study the role of GPCRs in immune regionalization of MALTs, at steady state and in disease.
Intestinal Analysis
In the intestine, we will:
- Phenotypically and functionally profile immune cells.
- Analyze GPCRs expression within Peyer's patches (PPs) from different gut regions, in physiology or in the context of inflammation and obesity.
Airway Analysis
Similarly, we will analyze immune regionalization of:
- Bronchus-associated lymphoid tissues.
- Nose-associated lymphoid tissues within the airways, at steady state or upon infections.
Candidate GPCR Characterization
Finally, we will characterize the role of a candidate GPCR, GPR35, in the induction of intestinal and respiratory immunity. Our preliminary data show that GPR35 shapes cell recruitment to inflamed airways and influences cell positioning within PPs.
Conclusion
By applying the above-mentioned approaches and dedicated mouse models, we will study how GPR35 regulates mucosal immunity and if it represents an attractive clinical target.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITA VITA-SALUTE SAN RAFFAELEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Innate lymphoid cells and tissue adaptation to changing metabolic needsThis project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases. | ERC ADG | € 2.379.266 | 2022 | Details |
Development of a new therapeutic product targeting neuroimmune circuits to treat asthmaThe IMMCEPTION 2 project aims to develop a selective GPCRX antagonist to treat asthma by blocking neuroimmune circuits, potentially leading to a new oral medication for patients. | ERC POC | € 150.000 | 2024 | Details |
Innate lymphoid cells and tissue adaptation to changing metabolic needs
This project aims to elucidate the role of ILC3 and the IL-22:IL-22BP module in intestinal adaptation to metabolic changes, with implications for understanding and treating metabolic diseases.
Development of a new therapeutic product targeting neuroimmune circuits to treat asthma
The IMMCEPTION 2 project aims to develop a selective GPCRX antagonist to treat asthma by blocking neuroimmune circuits, potentially leading to a new oral medication for patients.